Àλ縻 - ¹ÚÁ¾ÈÆ (´ëÇѾÏÇÐȸ ºÎȸÀå) |
09:20-09:30 |
|
|
|
1. High-throughput and computational methods to predict response
to cancer therapy |
09:30-11:00 |
|
ÁÂÀå: ÇãÈÆ (¾ÆÁÖÀÇ´ë) |
1) CRISPR/Cas9 gene editing platform for identifying cancer therapy |
±èÅÃÈÆ (KIST) |
2) Organoid for colon cancer reveals heterogenous response |
±¸ÀÚ·Ï (¼¿ïÀÇ´ë) |
3) Artificial intelligence to predict immunotherapy response in cancer patients |
±è»ó¿í (POSTECH) |
|
|
|
Coffee Break
|
11:00-11:20 |
|
|
|
2. Clinical application of liquid biopsy beyond ctDNA
|
11:20-12:50 |
|
ÁÂÀå: °ø¼±¿µ (±¹¸³¾Ï¼¾ÅÍ) |
1) MRD detection using ctDNA
| ½Å»õ¾Ï (¿¬¼¼ÀÇ´ë) |
2) True Real-time Answer with CTC Evaluation (TRACE): Toward practical utility
|
±è¹Î¼® (DGIST) |
3) The next therapeutic modality, extracellular vesicle
|
³²±âÈÆ (°í·ÁÀÇ´ë) |
|
|
|
Lunch Break |
12:50-14:00 |
|
|
|
3. Multidimensional immune cell analyses in immuno-oncology
|
14:00-15:30 |
|
ÁÂÀå: À̼ºÈ¯ (Â÷ÀÇ´ë) |
1) The use of multidimensional flow cytometry for immune biomarker discovery
| ±Ç¹Î¼® (¾ÆÁÖÀÇ´ë) |
2) Spatial multi-omics in immunology research
|
±èÁ¾ÈÆ (¿¬¼¼ÀÇ´ë) |
3) Multiplex IHC for immune monitoring |
±è»ó¿± (¼¿ï¾Æ»êº´¿ø) |
|
|
|
Coffee Break
|
15:30-15:50 |
|
|
|
4. Artificial Intelligence(AI) in drug discovery and development
|
15:50-17:20 |
|
ÁÂÀå: ÃÖÈ«À± (¼¿ïÀÇ´ë) |
1) Discover first-in-class drug candidates using workflow AI
| À±¼ÒÁ¤ (½ºÅÄ´ÙÀÓ) |
2) AI in the prediction of protein structure and interaction
|
¼®Â÷¿Á (¼¿ï´ë) |
3) Data-driven approaches for efficient drug discovery
|
±è¿Ï±Ô (ÀÌÈ¿©´ë) |